Cita APA

Sarli, M., Novoa, M. B., Mazzucco Panizza, M. N., Signorini, M., Echaide, I. E., Echaide, S. T. d., & Primo, M. E. (2020). A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. Web

Citación estilo Chicago

Sarli, Macarena, María Belen Novoa, Matilde Nahimé Mazzucco Panizza, Marcelo Signorini, Ignacio Eduardo Echaide, Susana T. de Echaide, and María Evangelina Primo. A Vaccine Using Anaplasma Marginale Subdominant Type IV Secretion System Recombinant Proteins Was Not Protective against a Virulent Challenge. 2020.

Cita MLA

Sarli, Macarena, et al. A Vaccine Using Anaplasma Marginale Subdominant Type IV Secretion System Recombinant Proteins Was Not Protective against a Virulent Challenge. 2020.